Remove Compliance Remove Containment Remove Engineer
article thumbnail

Comprehensive Guide to Medical Device Safety, Systems, and Regulatory Compliance: FAQ

Cloudbyz

Compliance with their regulations is mandatory for manufacturers seeking to market their devices globally. Regulatory compliance: Labels must comply with the regulations of the country in which the device is marketed, including language requirements, symbols, and content.

article thumbnail

Risk Assessment for use of Engineered Genetic Materials in Clinical Research

Advarra

The use of engineered genetic materials in clinical trials is rapidly expanding, with potential applications for genetic vaccines, gene-modified cellular therapies, and gene therapies. A key part of the IBC’s evaluation is assessing the risks posed by the engineered genetic materials. Why Does the IBC Need to do a Risk Assessment?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leading direct-to-consumer marketing companies for pharmaceuticals

Pharmaceutical Technology

Pharmaceutical companies have also entered the social media marketing domain in compliance with governmental regulations to communicate directly with patients using covert persuasion methods such as collaboration with social media influencers. Discover the leading direct-to-consumer pharmaceutical marketing companies.

Marketing 130
article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing decision. Pharmaceutical companies are increasingly integrating data-driven and software-centric medical adherence products to improve patient compliance. Patient adherence.

Pharmacy 130
article thumbnail

Thinking About the Box: Considerations for Transport of Investigational Products

Advarra

Controlled Environment and IP Containment The potential for a release, and the risk associated with a genetically engineered IP, are part of the IBC’s assessment purview under National Institutes of Health (NIH) Guidelines. The containment must then prevent spills or leaks if the IP is dropped. Size matters.

article thumbnail

How Potential Changes to the NIH Guidelines Could Impact IBC Review

WCG Clinical

Although the NIH Guidelines were originally written with non-clinical laboratory research in mind, they also apply to human gene transfer (HGT) research, wherein rsNA or rsNA-containing products are administered to research participants. Since then, however, certain genetic engineering technologies (e.g.,

Genome 52
article thumbnail

So Much More than Just Paperwork – The Importance of Design Controls for Device Start-ups

FDA Law Blog

It is common to refer to FDA regulations as either pre-market, meaning they are applied before the device may be marketed, or post-market, meaning that compliance is generally required only after the device is brought to market, with some exceptions.